 |
| Research article summary (published 22 Mar 2009): |
Tiling path genomic profiling of grade 3 invasive ductal breast cancers.
Full Abstract
PURPOSE: To characterize the molecular genetic profiles of grade 3 invasive ductal carcinomas of no special type using high-resolution microarray-based comparative genomic hybridization (aCGH) and to identify recurrent amplicons harboring putative therapeutic targets associated with luminal, HER-2, and basal-like tumor phenotypes. EXPERIMENTAL DESIGN: Ninety-five grade 3 invasive ductal carcinomas of no special type were classified into luminal, HER-2, and basal-like subgroups using a previously validated immunohistochemical panel. Tumor samples were microdissected and subjected to aCGH using a tiling path 32K BAC array platform. Selected regions of recurrent amplification were validated by means of in situ hybridization. Expression of genes pertaining to selected amplicons was investigated using quantitative real-time PCR and gene silencing was done using previously validated short hairpin RNA constructs. RESULTS: We show that basal-like and HER-2 tumors are characterized by "sawtooth" and "firestorm" genetic patterns, respectively, whereas luminal cancers were more heterogeneous. Apart from confirming known amplifications associated with basal-like (1q21, 10p, and 12p), luminal (8p12, 11q13, and 11q14), and HER-2 (17q12) cancers, we identified previously unreported recurrent amplifications associated with each molecular subgroup: 19q12 in basal-like, 1q32.1 in luminal, and 14q12 in HER-2 cancers. PPM1D gene amplification (17q23.2) was found in 20% and 8% of HER-2 and luminal cancers, respectively. Silencing of PPM1D by short hairpin RNA resulted in selective loss of viability in tumor cell lines harboring the 17q23.2 amplification. CONCLUSIONS: Our results show the power of aCGH analysis in unraveling the genetic profiles of specific subgroups of cancer and for the identification of novel therapeutic targets.
Author information
Author/s: Natrajan, Rachael (R); Lambros, Maryou B (MB); Rodríguez-Pinilla, Socorro María (SM); Moreno-Bueno, Gema (G); Tan, David S P (DS); Marchió, Caterina (C); Vatcheva, Radost (R); Rayter, Sydonia (S); Mahler-Araujo, Betania (B); Fulford, Laura G (LG); Hungermann, Daniela (D); Mackay, Alan (A); Grigoriadis, Anita (A); Fenwick, Kerry (K); Tamber, Narinder (N); Hardisson, David (D); Tutt, Andrew (A); Palacios, Jose (J); Lord, Christopher J (CJ); Buerger, Horst (H); Ashworth, Alan (A); Reis-Filho, Jorge S (JS);
Affiliation: The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res), published in United States. (Language: eng)
Reference: 2009-Apr; vol 15 (issue 8) : pp 2711-22
Dates: Created 2009/04/16; Completed 2009/06/04;
PMID: 19318498, status: MEDLINE (last retrieval date: 6/4/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
This article has not been indexed for related articles as yet, however you can still use the live related article search links below.
See a large map of 100+ related articles.